Francesco Caruana

Dr. Francesco Caruana

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
LALucas G. Axiotakis
Lucas G. Axiotakis
BSBetsy Szeto
Betsy Szeto
JGJoseph N. Gonzalez
Joseph N. Gonzalez
FCFrancesco Caruana
Francesco Caruana
David A. GudisDavid A. Gudis
David A. Gudis
JOJonathan B. Overdevest
Jonathan B. Overdevest

26 October 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
BVBrandon Jose Vilarello
Brandon Jose Vilarello
PJPatricia T. Jacobson
Patricia T. Jacobson
JTJeremy Paul Tervo
Jeremy Paul Tervo
LGLiam W. Gallagher
Liam W. Gallagher
FCFrancesco Caruana
Francesco Caruana
JOJonathan B. Overdevest
Jonathan B. Overdevest
(1) Background: Reports suggest COVID-19-associated olfactory dysfunction (OD) may result in alterations in dietary behaviors and perceived weight change, but few studies using psychophysical evaluation of post-COVID-19-associated chemosensory dysfunction and body mass index (BMI) exist. The purpose of this study is to assess the impact of both quantitative and qualitative features of COVID-19-associated OD on BMI; (2) Methods: Recruitment of thirty-one participants with self-reported OD in the form of quantitative loss with and without qualitative features. Surveys with questions specific to qualitative olfactory function, Sniffin’ Sticks tests, and BMI measures were completed at two visits, one year apart. Group differences were assessed with Wilcoxon signed-rank tests and the Holm–Bonferroni method; (3) Results: Individuals with persistent quantitative OD (n = 15) and self-reported parosmia (n = 19) showed statistically significant increases in BMI after 1 year (p = 0.004, adjusted α = 0.0125; p = 0.011, adjusted α = 0.0167). Controls with transient quantitative OD (n = 16) and participants without self-reported parosmia (n = 12) showed no statistically significant changes in BMI over the same time period (p = 0.079, adjusted α = 0.05; p = 0.028, adjusted α = 0.025); (4) Conclusions: This study shows an association between COVID-19-associated OD and BMI, suggesting olfaction may play a role in altering dietary habits and nutrition in this population. Larger study cohorts are needed to further evaluate this relationship.

19 December 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
TSTiana Saak
Tiana Saak
JTJeremy Paul Tervo
Jeremy Paul Tervo
BVBrandon J. Vilarello
Brandon J. Vilarello
PJPatricia T. Jacobson
Patricia T. Jacobson
FCFrancesco Caruana
Francesco Caruana
JOJonathan B. Overdevest
Jonathan B. Overdevest
Background/Objectives: Olfactory dysfunction (OD) is associated with a variety of neurologic deficits and impacts socialization decisions, mood, and overall quality of life. As a common symptom comprising the long COVID condition, persistent COVID-19-associated olfactory dysfunction (C19OD) may further impact the presentations of neuropsychiatric sequelae. Our study aims to characterize the longitudinal burden of depression, anxiety, and neuropsychiatric symptoms in a population with C19OD. Methods: Individuals with perceived C19OD completed a psychophysical screening evaluation of their sense of smell using the comprehensive Sniffin’ Sticks olfactory assessment. Only those with validated psychophysical OD were included in this prospective longitudinal study for baseline and one-year follow-up. Participants also completed PHQ-9, Beck Anxiety Inventory (BAI), and neuropsychiatric symptom questionnaires at each time point. Anxiety, depression, and neuropsychiatric symptom prevalence was calculated and compared between time points with Pearson’s chi-squared, Fisher’s exact, and Wilcoxon rank sum tests. Results: Each neuropsychiatric symptom evaluated in this study was reported by 13–49% of longitudinal cohort participants at both baseline and follow-up, except for seizure (0% at baseline and follow-up) and word-finding difficulty (61–68% at baseline and follow-up). Word-finding and focus difficulties were the most commonly reported symptoms. In total, 41% of participants reported some level of depression at baseline and 38% of participants reported depression at one-year follow-up, while 29% and 27% of participants reported some level of anxiety at respective time points. Conclusions: Individuals with C19OD are at risk for developing persistent neuropsychiatric conditions. These neurologic and psychiatric sequelae are persistent with repeated longitudinal assessment, even at nearly 2.5 years following initial COVID-19 diagnosis.

16 June 2023 in Operative Techniques in Otolaryngology-Head and Neck Surgery
Verified
Journal Article
Closed access
PJPatricia T. Jacobson
Patricia T. Jacobson
NYNathan Yang
Nathan Yang
FCFrancesco Caruana
Francesco Caruana
David A. GudisDavid A. Gudis
David A. Gudis
JOJonathan B. Overdevest
Jonathan B. Overdevest

30 June 2026 in OTO Open
Verified
Journal Article
Open access
FCFrancesco Caruana
Francesco Caruana
AGAlexander Gelbard
Alexander Gelbard
DFDavid Francis
David Francis
MPMichael J. Pitman
Michael J. Pitman
EKElena P. Kennedy
Elena P. Kennedy
SSShady Soliman
Shady Soliman
Objective: Characterize the long‐term vocal outcomes of patients who required ICU care for COVID‐19 infection. Study Design: Prospective cohort study. Setting: Multi‐institutional North American Airway Collaborative Study. Methods: Patients with a COVID‐19 diagnosis requiring ICU admission were identified via ICD‐10 codes and recruited after discharge to complete patient‐reported outcome measures (PROM) in voice (Voice Handicap Index: VHI‐10), communication (Communicative Participation Item Bank: CPIB), and breathing (Clinical COPD Questionnaire: CCQ). Multivariate analysis investigated the association between clinical variables and PROMs. Results: 308 patients enrolled; 271 were admitted with COVID to the ICU. 221 were intubated (81.5%); 50 patients admitted to the ICU did not require intubation (18.5%). Mean follow‐up was 489 days after discharge (95% CI: 452‐526). Mean intubation duration was 17 days (95% CI: 15‐19). Median endotracheal tube (ETT) size was 7.5. Intubation was associated with higher VHI‐10 score (15 vs 10; P = .01) and lower CPIB score (27 vs 30; P < .01). When controlling for ETT size, multivariate analysis did not show a relationship between intubation duration and VHI‐10 or CPIB scores but was associated with worse CCQ score ( P = .04). Conclusion: Survivors of COVID infection requiring ICU admission and intubation have persistent functional impairments in voicing and breathing more than 1 year after their hospitalization. While COVID survivorship and “long COVID” have centered on neuropsychiatric and metabolic outcomes, this study highlights the unappreciated negative impact of endotracheal intubation on voice and communication related to this illness and reinforces the relationship between duration of intubation and subjective dyspnea after surviving critical illness.